BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  What Offers Better Protection from COVID-19: Previous Infection or Vaccination?

  The question is continually being raised: what offers superior protection, a vaccine against COVID-19 or natural immunity?

  October 7, 2021

   · 

  3 min read

   · 

  Vanessa Doctor, RN
• 

  Policy

  Ginkgo Bioworks Hit After Short Seller Claims Business Model a ‘Shell Game’

  Litigator Block & Leviton is launching an investigation into Ginkgo Bioworks after short seller Scorpion Capital released a report alleging that Ginkgo is running a fraudulent operation.

  October 7, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Another Pfizer Exec Lines Up Retirement After COVID-19 Vaccine Mega-Win

  Pfizer’s exec team is hit with a double whammy as another c-suite leader announces his retirement.

  October 7, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Career Advice

  How to Handle Workplace Issues Directly

  Workplace issues can arise anytime so it is always better to be prepared to seek out the problems directly in a mannered way to avoid any kind of personal rivalry.

  October 7, 2021

   · 

  5 min read

   · 

  Karen Walpole
• 

  Deals

  Neumora Explodes onto Neuro Scene with $500 Million and Amgen Alliance

  Fresh out of the gates with $500 million in financing, Neumora Therapeutics forged a partnership with Amgen to develop and commercialize assets for neurodegenerative diseases.

  October 7, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Research Roundup: In the Unvaccinated, COVID-19 Reinfection May Still be Possible and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  October 7, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  Jury is Still Out on mRNA Vaccines’ Long-Term Effectiveness and More COVID News

  Here’s a look at mRNA vaccines and their effectiveness and more COVID-19 news.

  October 7, 2021

   · 

  6 min read

   · 

  Mark Terry
• 

  WHO Recommends Mass Rollout of GSK’s Malaria Vaccine in Sub-Saharan Africa

  GlaxoSmithKline shares jumped in aftermarket trading Wednesday after the WHO recommended broad deployment of the company’s malaria vaccine in sub-Saharan Africa and other areas.

  October 7, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Stakeholder Collaborations Essential to Making Things Happen in Rare Disease Space

  Patients and patient organizations, which have detailed insights in the natural history of a rare disease, should be integral, too.

  October 7, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Denali Moving Forward with Sanofi-Partnered ALS Candidate

  Denali Therapeutics reported positive Phase I data and regulatory progress for two therapeutics for ALS at the virtual 2021 Annual Northeast ALS Meeting.

  October 7, 2021

   · 

  3 min read

   · 

  Mark Terry